4. Cardiovascular risk estimation & Management of Cardiovascular Risk Factors Flashcards

1
Q

Why has CHD mortality declined?

A

Reduced disease incidence:

  • Primary prevention for at-risk people: Hypertension, lipid disorders, diabetes, weight management
  • Healthier lifestyle

Improved disease management:

  • Earlier treatment of acute events
  • More effective treatment of acute events
  • Secondary prevention
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Disparities

A

Socio-economic:
- Those who are most deprived have a 2-4 fold greater risk of CVD death in middle-age compared with those least deprived

Ethnicity:
- Maori are 2x likely to die from CVD & 1.5x likely to be hospitalised from CVD

Comorbidity:
- CVD risk is increased at an earlier age in those who experience serious mental health illnesses & have 1.5x higher chance of having a CV event

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cardiovascular risk

A
  • Genetic & environmental factors interact to create “intermediary” risk factors
  • Environmental factors include socioeconomic, socio-cultural aspects, income, education, housing
  • Primary prevention achieved through education & public policy
  • Secondary prevention & high risk intervention directed at individuals with either manifest clinical disease or high absolute risk profiles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Risk factors

A

Non-modifable:

  • Age
  • (Male) gender
  • Family history
  • Diabetes
  • Familial hyperlipidaemia
  • Clinical coronary, cerebrovascular, per vasc disease

Modifiable:

  • Cigarette smoking
  • Physical activity
  • Obesity
  • Dietary (western, high SF)
  • Psychosocial
  • Socioeconomic
  • HYPERTENSION
  • HYPERCHOLESTEROLAEMIA (high LDL, low HDL cholesterol)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Risk estimation - Assessment of CVD risk

A

Risk is estimated using:

  • Prior CVD event
  • Congestive heart failure
  • Familial hypercholesteroaemia
  • Patients with chronic kidney disease
  • Diabetes with overt nephropathy or other renal disease

PREDICT age range is 30-74 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Risk management - Shared treatment decisions

A

Take into account:

  • Individual’s 5 year combined CVD risk
  • Recommendations based on benefit, harms & cost effectiveness
  • Individuals clinical state, age, cormorbidities, frailty & life expectancy
  • Personal preferences for treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Hypertension guideline

A

Patients should aim for:

  • 140/85 if 5 yr risk < 15%
  • 130/80 if 5 year risk > 15%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Prevalence

A
  • ~40% of men & women have raised blood pressure

- Patients who are normotensive at age 55 have a 90% lifetime risk for developing hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Aetiology

A
  • 95% of hypertensives have essential hypertension
  • 2-5% have hypertension secondary to other causes

If secondary hypertension … treat the primary cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Consequence of hypertension

A
  • Stroke
  • Coronary artery disease
  • Left ventricular hypertrophy
  • Heart failure
  • Peripheral vascular disease
  • Renal disease
  • Retinopathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hypertension: Non-drug treatment

A
  • DASH eating plan
  • Reduce sodium intake
  • Physical activity
  • Moderation of alcohol consumption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hypertension: Drug treatments

A
  • ACE inhibitors OR ARBs
  • CCBs
  • Diuretics
  • Alpha-blockers OR spironolactone OR beta-blockers
  • Centrally acting agents, vasodilators
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Treatment resistant hypertension - Causes (exclusions)

A

“Failure to reach target BP in patients who are adhering to full doses of an appropriate 2-drug regimen that includes a diuretic”

  • Exclude secondary hypertension
  • Check BP measurement techniques
  • Check for non-adherence, inadequate doses or inappropriate combinations
  • Consider drug induced: NSAIDs/COX-2, sympathomimetics, OCP, corticosteroids, cyclosporin, tacrolimus, EPO, cocaine, amphetamines, illicit drugs
  • Consider OTC medicines
  • Check for volume overload, excess sodium intake, volume retention from kidney disease, obesity, excess alcohol intake
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Dyslipidaemia - hypercholesterolaemia

A

Risk factor for coronary heart disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Classification of lipidaemia

A

Primary - genetic

Secondary - acquired

  • Diabetes
  • Hypothyroidism
  • Renal failure
  • Obesity
  • Ethanol
  • Drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Optimum lipid profile

A
  • No established LDL-C treatment threshold
  • Secondary prevention have targets of 1.6-1.8 mmol/L - ideal level for primary & secondary
  • Target LDL-C reduction of 40% + is recommend on drug treatment
17
Q

Dyslipidaemia: Non-drug therapy

A
  • Diet & exercise
  • Less total & saturated fat
  • Less cholesterol
  • More poly-& mono-unsaturated fat
  • Same protein
  • More complex CHO & soluble fibre
18
Q

Dyslipidaemia: Drug therapy

A
  • HMG-CoA reductase inhibitors (Statins)
  • Ezetimibe & other plant sterols
  • PCSK9 inhibitors
  • Anion exchange resins (cholestyramine)
19
Q

Statins

A
  • Reduce LDL-C & increase HDL-C
  • Major S/E are myopathy & increased liver enzymes

Therapeutic benefits:

  • Reduce major coronary events
  • Reduce CHD mortality
  • Reduce coronary procedures (PTCA/CABG)
  • Reduce stroke
  • Reduce total mortality
20
Q

Monitoring of statins

A
  • Monitor non-fasting lipids every 6-12 months until target has been achieved & then annual monitoring thereafter
  • Check creatinine kinase in those with symptomatic muscle pain, tenderness or weakness
    + Lower/discontinue dose if experiencing muscle pain + CK rise & consider rechallenging once symptoms subside